582 Cholesterol levels increase on elexacaftor-tezacaftor-ivacaftor therapy but remain within acceptable ranges
| Autor: | Boyle, R., Xia, J., Patel, S., Ho, K., Lu, D., Lechtzin, N., Merlo, C., Allgood, S., West, N. |
|---|---|
| Zdroj: | In Journal of Cystic Fibrosis October 2023 22 Supplement 3:S310-S310 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect